Company: CYTK
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064529
Chunk: 0

Company: CYTOKINETICS INC
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
CYTOKINETICS, INCORPORATED 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(In thousands) (Unaudited)

     March 31, 2025

     December 31, 2024

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     73,680

     $
     94,857

     Short-term investments

     864,538

     981,157

     Accounts receivable

     2,012

     16,650

     Prepaid expenses and other current assets

     15,823

     15,276

     Total current assets

     956,053

     1,107,940

     Long-term investments

     150,687

     145,055

     Property and equipment, net

     67,175

     65,815

     Operating lease right-of-use assets

     77,439

     75,158

     Other assets

     12,697

     7,705

     Total assets
      
     $
     1,264,051

     $
     1,401,673

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Current liabilities:

     Accounts payable
      
     $
     13,942

     $
     20,369

     Accrued liabilities

     43,358

     55,323

     Short-term operating lease liabilities

     19,574

     18,978

     Current portion of long-term debt

     12,960

     11,520

     Derivative liabilities measured at fair value

     11,700

     11,300

     Deferred revenue

     52,370

     52,370

     Other current liabilities

     5,822

     9,814

     Total current liabilities

     159,726

     179,674

     Term loans, net

     92,025

     93,227

     Convertible notes, net

     553,143

     552,370

     Liabilities related to revenue participation right purchase agreements, net

     476,296

     462,192

     Long-term operating lease liabilities

     113,353

     112,582

     Liabilities related to RPI Transactions measured at fair